410 filings
Page 7 of 21
144/A
7n291e490bwb
8 May 23
Notice of proposed sale of securities (amended)
7:03pm
144
fh675w ocu0kiu7g
8 May 23
Notice of proposed sale of securities
4:40pm
4
roa35 xehj2ak7
8 May 23
Cerevel Therapeutics / N ANTHONY COLES ownership change
4:24pm
144
ck6by1xy ovfnyx
5 May 23
Notice of proposed sale of securities
3:15pm
144
hyv1f6so1tguecbf1
4 May 23
Notice of proposed sale of securities
2:50pm
144
g93wkx
4 May 23
Notice of proposed sale of securities
12:00am
8-K
gmok1gc
3 May 23
Cerevel Therapeutics Appoints Ron Renaud as President and Chief Executive Officer and Reports First Quarter 2023 Financial Results
6:39am
ARS
n2i2uoe dtt2jq
28 Apr 23
Annual report to shareholders
4:35pm
DEFA14A
hglr70
28 Apr 23
Additional proxy soliciting materials
4:20pm
SC 13D/A
cy3ff6p7d
25 Apr 23
Cerevel Therapeutics / PERCEPTIVE ADVISORS ownership change
12:00am
SC 13D
pkt9i
21 Apr 23
Cerevel Therapeutics / PERCEPTIVE ADVISORS ownership change
5:23pm
4
y8ux73qd4f mp1ec3
13 Apr 23
Cerevel Therapeutics / N ANTHONY COLES ownership change
4:48pm
144
ebc4k84lv1xxz440t
11 Apr 23
Notice of proposed sale of securities
4:40pm
4
nal1fw9uxjqg
6 Mar 23
Cerevel Therapeutics / N ANTHONY COLES ownership change
4:15pm
S-8
ngl3w7qlggpx5
22 Feb 23
Registration of securities for employees
4:38pm
8-K
xmibw
22 Feb 23
Cerevel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
6:48am
5
db1qixwwe kclw4
14 Feb 23
Cerevel Therapeutics / MARIJN E DEKKERS ownership change
5:52pm